US Approves Breakthrough Leukaemia Treatment That ‘Weaponises’ Blood Cells to Attack Cancer
31st August 2017
The Food and Drug Administration called the approval historic, the first gene therapy to hit the US market. Made from scratch for every patient, it’s one of a wave of “living drugs” under development to fight additional blood cancers and other tumours, too.